The actinic keratosis (AK) treatment market sits at the intersection of dermatology and skin cancer prevention, driven by persistent demand to treat sun-induced precancerous lesions before progression to invasive squamous cell carcinoma. AK is especially common in fair-skinned and aging populations with cumulative ultraviolet exposure, and diagnoses are rising with routine screening. From 2025...

Cancer treatment is undergoing a major transformation with the emergence of innovative biological therapies that selectively target tumor cells while stimulating the immune system. Among these advanced approaches, oncolytic virus therapy has gained significant attention due to its potential to improve treatment outcomes across multiple cancer types. Increasing research investments,...

The oncolytic virus therapy market is an emerging and strategically important segment of oncology—built around engineered or naturally tumor-selective viruses designed to infect, replicate within, and lyse cancer cells while stimulating anti-tumor immunity. Unlike traditional cytotoxic chemotherapy, oncolytic viruses (OVs) aim to convert “cold” tumors into more inflamed,...

The psychedelic drugs market  is moving from a research-led niche into a structured, clinic-delivered therapeutic category built around supervised dosing and psychotherapy support. Psychedelic-assisted therapies are being developed to address high-burden mental health conditions where conventional treatments often fall short—most notably treatment-resistant depression, PTSD,...

In-Depth Study on Executive Summary Tumor Immunotherapy Market Size and Share The Global Tumor Immunotherapy Market size was valued at USD 230.35 billion in 2024 and is expected to reach USD 499.19 billion by 2032, at a CAGR of 10.15% during the forecast period. The world class Tumor Immunotherapy Market business report presents with the continual...